Trinity Biotech (TRIB) News Today $0.66 -0.01 (-0.82%) Closing price 03/28/2025 03:56 PM EasternExtended Trading$0.66 -0.01 (-1.06%) As of 03/28/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Trinity Biotech (TRIB) Projected to Post Earnings on ThursdayMarch 27 at 1:17 AM | americanbankingnews.comCritical Analysis: TNF Pharmaceuticals (NASDAQ:TNFA) and Trinity Biotech (NASDAQ:TRIB)March 24, 2025 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.comMarch 22, 2025 | americanbankingnews.comTrinity Biotech files to sell 4.29M American Depositary Shares for holdersMarch 22, 2025 | markets.businessinsider.comTrinity Biotech receives non-compliance notice from NasdaqMarch 15, 2025 | markets.businessinsider.comTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price RequirementMarch 14, 2025 | globenewswire.comTrinity Biotech engages Barclays to advise on strategic realignment processMarch 13, 2025 | markets.businessinsider.comTrinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment ProcessMarch 13, 2025 | globenewswire.comTrinity Biotech announces additional funding for transformation planFebruary 28, 2025 | markets.businessinsider.comTrinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring TechnologyFebruary 28, 2025 | globenewswire.comTrinity Biotech stock hits 52-week low at $0.74 amid market challengesFebruary 11, 2025 | msn.comTrinity Biotech reports leap in CGM system accuracyFebruary 6, 2025 | msn.comTrinity Biotech reports findings from latest pre-pivotal trial on CGM systemFebruary 6, 2025 | markets.businessinsider.comTrinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal TrialFebruary 6, 2025 | globenewswire.comTrinity Biotech secures US funding for HIV testsFebruary 4, 2025 | msn.comTrinity Biotech faces US aid policy impact, PPP loan scrutinyJanuary 30, 2025 | msn.comTrinity Biotech announces results from pre-pivotal trial for CGM systemJanuary 29, 2025 | markets.businessinsider.comTrinity Biotech Shares Rise After Update on Next-Gen Blood-Sugar Monitoring DeviceJanuary 28, 2025 | marketwatch.comTrinity Biotech announces breakthrough in CGM technologyJanuary 28, 2025 | msn.comTrinity Biotech climbs after data for glucose monitoring deviceJanuary 28, 2025 | msn.comTrinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) TechnologyJanuary 28, 2025 | globenewswire.comTrinity Biotech revises credit terms to boost liquidityDecember 28, 2024 | uk.investing.comEuropean Equities Traded in US as American Depositary Receipts Tread Water Friday, Up 3% for WeekDecember 27, 2024 | msn.comTrinity Biotech announces amended credit agreement with PerceptiveDecember 25, 2024 | markets.businessinsider.comTrinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation PlanDecember 24, 2024 | globenewswire.comTrinity Biotech PLC ADRDecember 21, 2024 | wsj.comTrinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIVDecember 18, 2024 | globenewswire.comTrinity Biotech Files Prospectus for $1 Million ADS OfferingDecember 17, 2024 | tipranks.comEuropean Equities Traded in the US as American Depositary Receipts Decline in Monday TradingDecember 2, 2024 | msn.comTrinity Biotech Reports Q3 2024 Financial PerformanceNovember 19, 2024 | markets.businessinsider.comTrinity Biotech plc: Trinity Biotech Announces Q3 2024 Financial ResultsNovember 16, 2024 | finanznachrichten.deTrinity Biotech files to sell 650,000 American Depositary Shares for holdersNovember 15, 2024 | markets.businessinsider.comTrinity Biotech Plc (TRIB) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comTrinity Biotech plc Reports Q3 2024 Revenue Growth of 3% to $15.2 Million, Driven by Strong TrinScreen HIV Product DemandNovember 15, 2024 | quiverquant.comTrinity Biotech Announces Q3 2024 Financial ResultsNovember 15, 2024 | globenewswire.comInsights Ahead: Trinity Biotech's Quarterly EarningsNovember 14, 2024 | benzinga.comTrinity Biotech to Announce Q3 2024 Financial ResultsNovember 14, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Fall in Wednesday TradingNovember 13, 2024 | msn.comTrinity Biotech regains compliance with Nasdaq listing requirementsNovember 8, 2024 | markets.businessinsider.comTrinity Biotech Secures Nasdaq Compliance, Eyes GrowthNovember 8, 2024 | markets.businessinsider.comTrinity Biotech Invests in Rapid Sepsis Testing InnovationOctober 27, 2024 | markets.businessinsider.comTrinity Biotech acquires EpiCapture for initial $3M considerationOctober 25, 2024 | markets.businessinsider.comTrinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing PlatformOctober 25, 2024 | globenewswire.comTrinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCaptureOctober 25, 2024 | globenewswire.comBray life-sciences firm Trinity Biotech in row over $30m sale of Fitzgerald IndustriesOctober 20, 2024 | msn.comTrinity Biotech (NASDAQ:TRIB) Stock, Short Interest ReportOctober 10, 2024 | benzinga.comTrinity Biotech PLC (TRIB) Q2 2024 Earnings Call Highlights: Strong Point-of-Care Growth Amidst ...October 10, 2024 | finance.yahoo.comTrinity Biotech Reports Positive Pre-pivotal Study Data For Continuous Glucose Monitor TechnologyOctober 7, 2024 | markets.businessinsider.comTrinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor TechnologyOctober 7, 2024 | globenewswire.comTrinity Biotech Acquires Preeclampsia Prediction FirmSeptember 25, 2024 | finance.yahoo.com Remove Ads Get Trinity Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter. Email Address TRIB Media Mentions By Week TRIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRIB News Sentiment▼0.470.80▲Average Medical News Sentiment TRIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRIB Articles This Week▼31▲TRIB Articles Average Week Remove Ads Get Trinity Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Verrica Pharmaceuticals News Today Outlook Therapeutics News Today Actinium Pharmaceuticals News Today Repare Therapeutics News Today iBio News Today Kezar Life Sciences News Today Spero Therapeutics News Today Celularity News Today Connect Biopharma News Today Precision BioSciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TRIB) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew Pick (93% history of rising by May 8)We just posted a new recommendation. Keep in mind: You could have boosted the Netflix trade we issued to the p...InvestorPlace | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.